MedTrace Logo

Etiology and Incidence Assessment of Radiographically-confirmed Community Acquired Pneumonia (CAP)

NCT03606135 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2020-04-03

No results posted yet for this study

Summary

This is an epidemiological study to investigate the etiology of radiographically-confirmed community-acquired pneumonia (CAP) in adults aged ≥18 years. The main objective is to determine the proportion of which cases that is due to Streptococcus pneumoniae and the corresponding incidence and serotype distribution. The study will utilize a serotype-specific urinary antigen detection (UAD) assay.

Conditions

Interventions

OTHER

The Pneumonia Group

OTHER

The Control Group

Sponsors & Collaborators

  • Pfizer

    collaborator INDUSTRY

  • Region Skane

    lead OTHER

Principal Investigators

  • Jonas Ahl, MD, PhD · Department of Infectious Diseases

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-09-17
Primary Completion
2018-12-31
Completion
2018-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03606135 on ClinicalTrials.gov